Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure.

about

Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure.

Item

http://www.wikidata.org/entity/Q49314984

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Haploidentical hematopoietic s ...... nt with primary graft failure.

@en

Haploidentical hematopoietic s ...... nt with primary graft failure.

@nl

type

Item

label

Haploidentical hematopoietic s ...... nt with primary graft failure.

@en

Haploidentical hematopoietic s ...... nt with primary graft failure.

@nl

prefLabel

Haploidentical hematopoietic s ...... nt with primary graft failure.

@en

Haploidentical hematopoietic s ...... nt with primary graft failure.

@nl

P1476

Haploidentical hematopoietic s ...... nt with primary graft failure.

@en

P2093

Alberto Zamò

http://www.w3.org/2001/XMLSchema#string

Angelo Andreini

http://www.w3.org/2001/XMLSchema#string

Cristina Tecchio

http://www.w3.org/2001/XMLSchema#string

Donata de Sabata

http://www.w3.org/2001/XMLSchema#string

Emanuele Guardalben

http://www.w3.org/2001/XMLSchema#string

Fabio Benedetti

http://www.w3.org/2001/XMLSchema#string

Fiorenza Aprili

http://www.w3.org/2001/XMLSchema#string

Roberta Galavotti

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

European consensus on grading bone marrow fibrosis and assessment of cellularity.

Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplan

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Genetic Risk Assessment in Myeloproliferative Neoplasms.

P304

7091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/HR.2017.7091

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Costantini

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29383224

http://www.w3.org/2001/XMLSchema#string

P932

5768082

http://www.w3.org/2001/XMLSchema#string